MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Ri... ( SAN FRANCISCO Oct. 29 /- MedImmun...)

MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV

Date:10/29/2007

SAN FRANCISCO, Oct. 29 /PRNewswire/ -- MedImmune today announced results from a recent economic analysis of Synagis(R) (palivizumab), a monoclonal antibody (MAb) that is the standard of care for prevention of severe lower respiratory tract infection due to respiratory syncytial virus (RSV) in high- risk infants. Released at the American Academy of Pediatrics (AAP) 2007 National Conference & Exhibition, the analysis evaluated the costs of providing Synagis to premature infants, as well as the potential health benefits and cost savings that could occur from lower rates of severe RSV infections.

RSV can cause severe lower respiratory tract infections in preterm infants. However, recent data have suggested that RSV infection early in an infant's life may cause subsequent chronic respiratory complications such as persistent wheezing.

Dr. Mark Polak, a neonatologist and professor of pediatrics from the West Virginia University School of Medicine and lead author of the economic analysis, noted, "We factored in the potential costs of possible future complications and the quality of life associated with persistent wheezing and, based on these assumptions, our study found that preventing RSV early in life makes economic sense."

The authors noted that more evidence is needed to substantiate the linkage between Synagis and subsequent reductions in persistent wheezing.

MedImmune's Commitment to RSV Prevention

MedImmune is a world leader in the development of innovative therapeutic biologic products to prevent RSV disease. In 1996, MedImmune launched the first anti-RSV drug, RespiGam(R) (respiratory syncytial virus immune globulin intravenous (human) (RSV-IGIV)), which was a polyclonal antibody administered via four-hour intravenous infusion. In 1998, MedImmune introduced Synagis, which was a significant product improvement as a monthly intramuscular injection for the prevention of severe RSV, as well as being the first MAb to receive U.S. Foo
'/>"/>

SOURCE MedImmune
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Infinity and MedImmune Present Updated Phase I Results of IPI-504 in GIST at ASCO Annual Meeting
2. Infinity and MedImmune Announce Updated Data On Ipi-504 to be Presented At ASCO
3. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
4. MedImmune Announces Positive Clinical Results at PAS Annual Meeting From Large Prospective Trial in Prevention of Serious RSV Disease
5. Pediatric Academic Societies Annual Meeting to Feature Data Presentations Related to MedImmune Clinical Programs in Influenza, RSV and hMPV
6. Micromet Achieves Milestone in BiTE Research Collaboration with MedImmune
7. MedImmune Publishes New Data in Nature Immunology Demonstrating The Role HMGB1 May Play in Systemic Autoimmune Diseases
8. MedImmune and Micromet Publish Data on Novel Anti-Cancer BiTE Molecule
9. Micromet and MedImmune Present Data From Preclinical Study of New BiTE Molecule Targeting CEA
10. Infinity and MedImmune to Present Preclinical Data From Study of Oral Formulation of IPI-504 At AACR
11. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting

Post Your Comments:

(Date:3/18/2010)... March 18 Peter Derycz , Chairman ... DYSC), a company that is pioneering a fresh way ... to enterprise customers and their constituents, has contributed articles ... Genetic Engineering & Biotechnology News . Both articles discuss ...

(Date:3/17/2010)... LLY ) today issued a statement and details regarding the stolen company products from its distribution operations in Enfield, Connecticut on Sunday, March 14 . , ... , ... ... ...

(Date:3/17/2010)... Esteem approved to treat sensorineural hearing loss , ... , , ... ... SILVER SPRING, Md. , March 17 ...

Breaking Medicine Technology:Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News 2 Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News 3 Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News 4 Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations 2 Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations 3 Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations 4 Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations 5 Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations 6 Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations 7 Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations 8 FDA Approves First Totally Implanted Hearing System 2 FDA Approves First Totally Implanted Hearing System 3 FDA Approves First Totally Implanted Hearing System 4 FDA Approves First Totally Implanted Hearing System 5 While Most Businesses are Laying Off Their Employees The Logo Loft Continues to Hire U S Graphic Designers 61366 1 While Most Businesses are Laying Off Their Employees The Logo Loft Continues to Hire U S Graphic Designers 61366 2 Federal Court Appoints Onder Law Firm Partner as Co Lead Counsel to the Plaintiffs 26apos 3B Steering Committee of the Multi District Litigation for Y 61363 1 Federal Court Appoints Onder Law Firm Partner as Co Lead Counsel to the Plaintiffs 26apos 3B Steering Committee of the Multi District Litigation for Y 61363 2 Federal Court Appoints Onder Law Firm Partner as Co Lead Counsel to the Plaintiffs 26apos 3B Steering Committee of the Multi District Litigation for Y 61363 3 In touch with molecules 14836 1 In touch with molecules 14836 2

[0] Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News [0] Statement From Eli Lilly and Company Regarding Stolen Company Products From Enfield, Connecticut Distribution Operations [0] FDA Approves First Totally Implanted Hearing System

... 21 Nostrum, a privately-held,company based in ... has,successfully completed its early, primate, proof-of-concept study ... as SMRX11. Nostrum,s,Symmetrix subsidiary, based in Singapore, ... license from the Institute of Microbial,Technology, Chandigarh, ...

... Use of HIV-specific T cell Precursors with High ... (PHPC) Marker to Predict Reduction of Viral Load, ... Genetic,Immunity(R), a US/Hungarian clinical-stage company focused on ... Journal of,Immunology published findings on a key biomarker ...

Other Medicine Technology:Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein 2 Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology 2 Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology 3

Nostrum Announces the Successful Completion of Early Proof-of-Concept Study for its Novel Clot Busting Therapeutic Protein Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology

(Date:3/22/2010)... expanded services and features to meet a growing and urgent need for ... of the population) were over the age of 65. By the year ... to 23%. , ... Foster City, Calif. (PRWEB) March 22, 2010 ... and features to meet a growing and urgent need for elder care ...

(Date:3/22/2010)... nationally-recognized orthopedic hospital. , ... Oklahoma City, OK (PRWEB) ... entered into an agreement with the Orthopedic Institute to ... and the Orthopedic Hospital, effective January 1, 2010, reports ... to day operation of the facilities and their performance. , , ...

(Date:3/21/2010)... ... , , ... ... ... , March 21 Today the House of Representatives passed the Senate health care bill with a multitude of abortion funding provisions ...

(Date:3/21/2010)... WASHINGTON , March 22 Speaker Nancy Pelosi spoke on ... the Senate version of health insurance reform legislation by a vote of 219 to 212. ... to improve the Senate bill, passed by a vote of 220 to 211 and goes ... ... ...

(Date:3/21/2010)... used stair lifts, 4 Stair Lifts, will now buy back used lifts ... sell them at discounted prices. , ... (Vocus) March 21, 2010 -- ... buy back used stair lifts from AmeriGlide and Summit. The ... and then make sure they are working correctly before putting them on ...

[0] ElderCarelink.com New Look and Expanded Services Meet Growing Needs For Elder Care in the U.S. [0] Cornerstone Health Corporation Named Manager of Orthopedic Institute's Hospital and Tower Day Surgery Center [0] Pro-Life Movement Vows to Replace Members From Pro-life Districts Who Voted for the Most Pro-Abortion Bill Ever Passed by Congress [0] Pelosi: 'Today, We Have the Opportunity to Complete the Great Unfinished Business of Our Society and Pass Health Insurance Reform for All Americans'[0] 4 Stair Lifts Announces Used Stair Lift Buy Back Program

... $250,000 - 1.75 million meals - to Feeding ... April 3 Healthy Choice, the brand that ... focusing on what people want from their food ... entree category. After 20 years of delivering nutritious ...

... Berlin Heart GmbH today announced it has,received ... EXCOR(R),Pediatric ventricular assist device received the License with ... regulatory issues in,Canada. , ... cardiac support system,for critically ill pediatric patients suffering ...

... office.MINNEAPOLIS, April 3 Thomas, McNerney & Partners, LLC, ... life science and medical technology companies, today announced that ... firm,s Minneapolis office. From 2000 to 2008, Mr. DeMane ... MDT ) U.S. and global operations, most recently ...

... expected to soar after regulatory approvals for the first medicine for ... ... Los Angeles, CA (PRWEB) April 3, 2009 -- American ... find no relief from the overseas approval of dapoxetine. Marketed under ...

... by a loving daughter who knows the struggles ... needs and multiple medications, MyMedManager™ is a new ... all ages or their caregivers to keep track ... easy-to-understand, and portable spiral binder, MyMedManager™ is the ...

... As news emerged that Gov. Kathleen Sebelius, ... been postponed until the end of April, American ... and Pat Roberts to reject the nomination.(Logo: ... "Senatorial Courtesy" -- the longstanding Senate tradition only ...

Other Medicine News:Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 2 Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 3 Health News:Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus 4 Health News:Berlin Heart Receives First Regulatory Approval in North America 2 Health News:Michael DeMane Joins Thomas, McNerney & Partners as Senior Advisor 2 Health News:New P.E. Drug Approved In Europe While Premature Ejaculation Cure Remains Out of Reach to American Men 2 Health News:New P.E. Drug Approved In Europe While Premature Ejaculation Cure Remains Out of Reach to American Men 3 Health News:New Medical Organizer Allows People to Easily Manage Their Own Healthcare 2 Health News:New Medical Organizer Allows People to Easily Manage Their Own Healthcare 3 Health News:A.L.L. Calls on KS Senators to Stop Sebelius as Confirmation Postponed 2

Healthy Choice Reinvents Brand With New Products, A New Look And New Campaign Featuring Julia Louis-Dreyfus Berlin Heart Receives First Regulatory Approval in North America Michael DeMane Joins Thomas, McNerney & Partners as Senior Advisor New P.E. Drug Approved In Europe While Premature Ejaculation Cure Remains Out of Reach to American Men New Medical Organizer Allows People to Easily Manage Their Own Healthcare A.L.L. Calls on KS Senators to Stop Sebelius as Confirmation Postponed

Simplicity and multi-directional retraction for a broad range of abdominal procedures...

... The genuine BOOKWALTER™ Retractor System ... fixed" retractor design available. Its wide ... surgical specialites with a versatile system ... field. Individual BOOKWALTER™ Kits are available ...

Rainbow technology combines the latest in system theory, adaptive signal processing and a revolutionary sensor that employs eight wavelengths of light to collect and analyze an extraordinarily rich s...

... Another breakthrough in real-time PCR analysis ... mutation analysis. ,The LightCycler 480 System ... and will meet the needs of ... in genomics research including array validation, ...

Medicine Products:

Workhorse™ Retractor BOOKWALTER™ Retractor Systems Rad-57 LightCycler 480 System

MedImmune Presents New Pharmaco-Economic Data at American Academy of Pediatrics Regarding Infants at High Ri...( SAN FRANCISCO Oct. 29 /- MedImmun...),Health